Molluscum contagiosum

31st July 2015 by NASGP

Molluscum contagiosum

molluscumUntil now, the best treatment was to do nothing, but could a new drug, MolluDab, offer a cure? This DTB article reviews the evidence (DTB 2014;52(10):110).

MolluDab is 5% potassium hydroxide solution applied twice daily with a dabber. An inflammatory response should occur after 4-6d with lesions disappearing over the next 1-5w. It is available over the counter (OTC) and on prescription (except in Scotland). The RRP is £24.30 for 2ml! The main side effect is stinging/burning, with redness, itching, pain, ulceration, crusting and hyperpigmentation also reported.

The two main trials were tiny (<30 patients). The DTB review concluded there was no convincing effect and do not recommend prescribing it.

Read more

No bank details needed.

Join free trial


Already a member? Login to view this content.


"I am so glad and grateful for being a member of NASGP's BOB locum chambers. I started with them in a critical period of my career as I was a newly-qualified GP, looking for work in a new area with a new virus hardly hitting the world and the jobs market.

Richard and Ali's help was a godsend. They introduced me to locum work in a friendly and kind manner, provided valuable support and excellent service through the ever-improving LocumDeck and NASGP website. With the help of the chambers, I received a face to face tutorial on Emis (I trained on SystmOne) and my online profile was promoted on a growing network of GP practices throughout Buckinghamshire, Oxford and Berkshire.

I was able to work in different GP practices with different staff and patient demographics, massively increasing my clinical experience, resilience and communication skills.

It also helped me funnelling down all the job offers I received through my locum work until I recently agreed for a salaried position in a GP practice that I love working at. "

Dr Nazar Ahmed, Oxford

See the full list of features within our NASGP membership plans